相关实验视频
Updated: May 5, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.1K
过敏反应注册的最新发现:我们在哪里,我们想去哪里?
Margitta Worm1, Sabine Dölle-Bierke1, Lea Faust1
1Allergology and Immunology, Clinic for Dermatology, Venereology and Allergology, Campus Charité Mitte, Universitätsmedizin Berlin, Berlin, Germany.
Allergologie select
|March 19, 2025
概括
欧洲过敏反应注册揭示了常见的触发因素,如儿童的食物和成年人的昆虫毒液. 罕见的过敏原,包括香料和蔬菜,越来越多地被确定为严重过敏反应的原因.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 公共卫生监督 公共卫生监督
背景情况:
- 过敏反应是一种严重的过敏反应,它需要对其原因和管理进行全面的数据收集.
- 欧洲登记处对于了解不同人群中严重过敏反应的趋势至关重要.
- 识别特定的诱导因子和患者人口统计数据是有效预防和治疗过敏反应的关键.
研究的目的:
- 分析欧洲过敏反应登记处关于严重过敏反应的数据.
- 在不同年龄组中识别常见和罕见的过敏反应诱因.
- 调查过敏反应病例中的人口统计差异和症状模式.
主要方法:
- 通过整个欧洲的结构化注册表收集数据.
- 分析到2024年3月16988例注册的过敏反应病例.
- 病例按年龄 (儿童与成人),诱发者和症状进行分类.
主要成果:
- 食物过敏原是儿童的主要触发因素;昆虫毒液在成年人中占主导地位.
- 没有皮肤症状的过敏反应发生在5%的儿童和高达15%的成年人中.
- 罕见的食物过敏原,如沙夫兰,苏麦,西瓜和虫被确定为触发因素.
结论:
- 过敏反应触发者的人口和年龄差异是显著的.
- 植物性饮食日益普及,需要对更广泛的食物过敏原进行监测.
- 罕见的过敏原构成风险,需要持续监测以评估过敏反应的风险.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Pharmacovigilance
762
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
762
Allergic Drug Reactions
800
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
800
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
204
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
204
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K

